ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,953, issued on Sept. 22, was assigned to Shanghai Jeyou Pharmaceutical Co. Ltd. (Shanghai).
"Phthalazinone compound, and preparation method therefor and medical use thereof" was invented by Hongfu Lu (Shanghai), Weiqiang Xing (Shanghai), Yongcong Lv (Shanghai), Baojian Qi (Shanghai), Jianbiao Peng (Shanghai) and Haibing Guo (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a phthalazinone compound, and a preparation method therefor and the medical use thereof. In particular, disclosed are a compound as represented by formula (I), and a pharmacodynamically acceptable salt, and the use of the compound as an androgen receptor (AR)...